Novel biomarkers to predict treatment response and prognosis in locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy

[11] Fedewa SA(2022)Preoperative chemoradiotherapy with capecitabine and triweekly oxaliplatin versus capecitabine monotherapy for locally advanced rectal cancer: a propensity-score matched study BMC Cancer 22 789-44

[12] Butterly LF(2008)WGCNA: an R package for weighted correlation network analysis BMC Bioinformatics 9 559-72

[13] Anderson JC(2021)The Prognostic significance of APOBEC3B and PD-L1/PD-1 in nasopharyngeal carcinoma Appl Immunohistochem Mol Morphology: AIMM 29 239-70

[14] Cercek A(2009)CellMiner: a relational database and query tool for the NCI-60 cancer cell lines BMC Genomics 10 277-18

[15] Smith RA(2011)Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of european randomized clinical trials J Clin Oncol 29 3163-112e102

[16] Jemal A(2021)Risk stratification using neoadjuvant rectal score in the era of Neoadjuvant Chemoradiotherapy: Validation with Long-term Outcome Data Dis Colon Rectum 64 60-6

[17] Li Y(2020)Prognostic significance of Neoadjuvant rectal scores in Preoperative Short-Course Radiotherapy and Long-Course Concurrent Chemoradiotherapy for patients with locally advanced rectal Cancer Ann Surg Oncol 27 4309-9

[18] Wang J(2018)Integrating downstaging in the Risk Assessment of patients with locally advanced rectal Cancer treated with Neoadjuvant Chemoradiotherapy: validation of Valentini’s Nomograms and the neoadjuvant rectal score Clin Colorectal Cancer 17 104-31

[19] Ma X(2019)Disqualification of neoadjuvant rectal score based on data of 6596 patients from the Netherlands Cancer Registry Clin Colorectal Cancer 18 e231-94

[20] Tan L(2019)Assessment of a Watch-and-wait strategy for rectal Cancer in patients with a complete response after Neoadjuvant Therapy JAMA Oncol 5 e185896-15

[11] Fedewa SA(2022)Preoperative chemoradiotherapy with capecitabine and triweekly oxaliplatin versus capecitabine monotherapy for locally advanced rectal cancer: a propensity-score matched study BMC Cancer 22 789-44

[12] Butterly LF(2008)WGCNA: an R package for weighted correlation network analysis BMC Bioinformatics 9 559-72

[13] Anderson JC(2021)The Prognostic significance of APOBEC3B and PD-L1/PD-1 in nasopharyngeal carcinoma Appl Immunohistochem Mol Morphology: AIMM 29 239-70

[14] Cercek A(2009)CellMiner: a relational database and query tool for the NCI-60 cancer cell lines BMC Genomics 10 277-18

[15] Smith RA(2011)Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of european randomized clinical trials J Clin Oncol 29 3163-112e102

[16] Jemal A(2021)Risk stratification using neoadjuvant rectal score in the era of Neoadjuvant Chemoradiotherapy: Validation with Long-term Outcome Data Dis Colon Rectum 64 60-6

[17] Li Y(2020)Prognostic significance of Neoadjuvant rectal scores in Preoperative Short-Course Radiotherapy and Long-Course Concurrent Chemoradiotherapy for patients with locally advanced rectal Cancer Ann Surg Oncol 27 4309-9

[18] Wang J(2018)Integrating downstaging in the Risk Assessment of patients with locally advanced rectal Cancer treated with Neoadjuvant Chemoradiotherapy: validation of Valentini’s Nomograms and the neoadjuvant rectal score Clin Colorectal Cancer 17 104-31

[19] Ma X(2019)Disqualification of neoadjuvant rectal score based on data of 6596 patients from the Netherlands Cancer Registry Clin Colorectal Cancer 18 e231-94

[20] Tan L(2019)Assessment of a Watch-and-wait strategy for rectal Cancer in patients with a complete response after Neoadjuvant Therapy JAMA Oncol 5 e185896-15